🧬 TrialLead AI — ClinicalTrials.gov Biotech Pipeline & Principal Investigator Radar

Unlock real-time clinical trial intelligence, lead Principal Investigators (PIs), biotech sponsors, and direct contact emails from the official US National Library of Medicine (NLM) registry.

---

💡 What is TrialLead AI?

Every year, pharmaceutical giants and venture-backed biotechs launch thousands of multi-million dollar clinical trials across oncology, immunology, neuroscience, rare diseases, and gene therapy.

Before a drug is announced at medical conferences or hits industry newsletters, federal regulations mandate that the study protocol be filed on ClinicalTrials.gov.

TrialLead AI turns the official US Government clinical registry into a real-time B2B lead generation engine, extracting not just dry trial IDs, but direct contact emails, lead Principal Investigators (PIs), commercial sponsor tags, and recruitment urgency signals.

---

🎯 High-Value Arbitrage & Use Cases

Industry / Role	How They Profit From This Data
👔 Life Science Recruiters & Headhunters	Placement fees for Clinical Trial Managers, Medical Monitors, and PIs range from $20,000 to $50,000 per hire. Find who is actively leading clinical trials before they get headhunted.
🏥 Contract Research Organizations (CROs)	Target newly approved trials in NOT_YET_RECRUITING status (the pre-launch golden window) to pitch trial management, patient recruitment, and biostatistical services worth $500k–$5M+.
🧪 Pharma & Lab Suppliers	Sell cold storage units, assay reagents, centrifuge hardware, and diagnostic consumables to trial sites before patient enrollment begins.
📈 Biotech Investors & Hedge Funds	Track pipeline transitions (Phase 1 $\to$ Phase 2 $\to$ Phase 3), enrollment velocity, and competitor drug pipelines in real time.
🤝 Medical Affairs & MSLs	Map key opinion leaders (KOLs) and clinical site coordinators across specialized therapeutic areas.

---

⚡ What Data You Get

For every clinical study matched, TrialLead AI normalizes and outputs:

• Study Identification: nctId, briefTitle, officialTitle, studyUrl, studyType
• Commercial Classification: leadSponsorName, leadSponsorClass (INDUSTRY, NIH, FED, OTHER), isIndustrySponsored, collaborators
• Lead Investigator Rolodex: principalInvestigator, principalInvestigatorRole, principalInvestigatorAffiliation, full allInvestigators array
• Direct Contact Rolodex: primaryContactName, primaryContactEmail, primaryContactPhone, allContactEmails, allContactPhones
• Trial Timeline & Urgency: overallStatus, recruitmentUrgency (Pre-Launch vs Actively Recruiting), startDate, completionDate, firstPostedDate
• Therapeutic Modality: modality (Biologic / Cell & Gene Therapy, Small Molecule Drug, Medical Device, etc.)
• Trial Scale: enrollmentCount, locationsCount, countries, states
• Interventions & Conditions: conditions list, interventions list, detailed arms descriptions
• Commercial Lead Score: Proprietary 1–100 sales score based on industry funding, phase maturity, enrollment scale, and contact availability.

---

🚀 Key Input Filters

• 🔬 Condition / Disease Area: e.g., oncology, alzheimer's, type 2 diabetes, obesity, glp-1, rare diseases, solid tumors.
• 💊 Drug / Intervention: e.g., pembrolizumab, semaglutide, mRNA-4157, CAR-T.
• 🏢 Sponsor: e.g., Pfizer, Moderna, Eli Lilly, Novartis.
• 🚨 Recruitment Status: NOT_YET_RECRUITING (pre-launch golden window), RECRUITING, COMPLETED.
• 📈 Trial Phase: Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4.
• 🏛️ Sponsor Type: Industry Only (commercial pharma/biotech), NIH, Federal, Academic.
• 🌍 Country: Filter by specific trial country (e.g., United States, United Kingdom, Germany) or ALL.

---

📋 Sample Output Record (JSON)

{
  "nctId": "NCT07822373",
  "briefTitle": "A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin",
  "studyUrl": "https://clinicaltrials.gov/study/NCT07822373",
  "overallStatus": "RECRUITING",
  "recruitmentUrgency": "🟢 Actively Recruiting",
  "phaseFormatted": "Phase 2",
  "modality": "Biologic / Cell & Gene Therapy",
  "conditions": [
    "Urothelial Carcinoma",
    "Bladder Cancer"
  ],
  "interventions": [
    "Enfortumab Vedotin",
    "Pembrolizumab"
  ],
  "leadSponsorName": "Seagen Inc. / Astellas Pharma",
  "leadSponsorClass": "INDUSTRY",
  "isIndustrySponsored": true,
  "principalInvestigator": "Derek Johnson, MD",
  "principalInvestigatorRole": "PRINCIPAL_INVESTIGATOR",
  "principalInvestigatorAffiliation": "Mayo Clinic Comprehensive Cancer Center",
  "primaryContactName": "Clinical Trial Navigators",
  "primaryContactEmail": "clinicaltrials@seagen.com",
  "primaryContactPhone": "1-855-473-2436",
  "enrollmentCount": 120,
  "locationsCount": 15,
  "countries": ["United States"],
  "states": ["California", "New York", "Texas"],
  "startDate": "2026-04-15",
  "firstPostedDate": "2026-09-16",
  "commercialLeadScore": 95
}

---

💰 Transparent Pay-Per-Event (PPE) Pricing

Event	Price
🚀 Actor Run Start	$0.003
📥 Per Trial Lead Extracted	$0.005

Example: Extracting 200 high-value Phase 2/3 oncology trial leads costs just $1.00.

---

🏆 Golden Standard Guarantees

• 100% Authentic Government Data: Direct from official US NLM API v2 — zero mock, synthetic, or fake data.
• Zero Browser Overhead: Sub-second HTTP execution without headless browser lag.
• Always Up-To-Date: Access newly posted clinical trials minutes after they are accepted by the FDA / NLM.